UPH - UpHealth, Inc. Stock Price, Fair Value and News

96.00USD+3.00 (+3.23%)Market Closed

Market Summary

USD96.00+3.00

Market Closed

3.23%

UPH Stock Price

View Fullscreen

UPH RSI Chart

UPH Valuation

Market Cap

1.8B

Price/Earnings (Trailing)

-31.48

Price/Sales (Trailing)

13.89

EV/EBITDA

-78.46

Price/Free Cashflow

-83.47

UPH Price/Sales (Trailing)

UPH Profitability

EBT Margin

-44.33%

Return on Equity

-104.1%

Return on Assets

-24.75%

Free Cashflow Yield

-1.2%

UPH Fundamentals

UPH Revenue

Revenue (TTM)

130.0M

Rev. Growth (Yr)

-57.16%

Rev. Growth (Qtr)

-46.91%

UPH Earnings

Earnings (TTM)

-57.4M

Earnings Growth (Yr)

61.41%

Earnings Growth (Qtr)

49.03%

Breaking Down UPH Revenue

Last 7 days

-1.6%

Last 30 days

-7.9%

Last 90 days

7.5%

Trailing 12 Months

-2.6%

How does UPH drawdown profile look like?

UPH Financial Health

Current Ratio

0.75

UPH Investor Care

Shares Dilution (1Y)

19.59%

Diluted EPS (TTM)

-3.23

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	165.0M	159.1M	153.1M	130.0M
2022	147.0M	158.7M	152.2M	158.8M
2021	17.3M	49.1M	94.3M	123.8M
2020	2.8M	2.6M	1.7M	5.4M
2019	0	0	0	0

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of UpHealth, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Nov 27, 2023	beck martin s a	sold (taxes)	-427	0.61	-701	chief executive officer
Nov 21, 2023	katz avi s	sold	-112	0.4	-280	-
Aug 22, 2023	beck martin s a	sold (taxes)	-932	1.33	-701	chief executive officer
Jun 01, 2023	beck martin s a	sold (taxes)	-1,718	1.5164	-1,133	chief financial officer
May 22, 2023	beck martin s a	sold (taxes)	-2,573	1.7403	-1,479	chief financial officer
Mar 13, 2023	beck martin s a	sold (taxes)	-1,717	1.7601	-976	chief financial officer
Feb 03, 2023	beck martin s a	sold (taxes)	-1,444	2.65	-545	chief financial officer
Jan 09, 2023	meckey samuel	acquired	-	-	430,000	chief executive officer
Dec 16, 2022	machuca luis	acquired	-	-	60,606	-
Dec 16, 2022	guinan mark	acquired	-	-	60,606	-

Which funds bought or sold UPH recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 02, 2024	Greenhaven Road Investment Management, L.P.	sold off	-100	-2,000	-	-%
Apr 02, 2024	Greenhaven Road Investment Management, L.P.	sold off	-100	-1,106,000	-	-%
Mar 26, 2024	HighPoint Advisor Group LLC	new	-	14,000	14,000	-%
Mar 11, 2024	VANGUARD GROUP INC	sold off	-100	-283,507	-	-%
Feb 26, 2024	Virtu Financial LLC	sold off	-100	-22,000	-	-%
Feb 16, 2024	Context Capital Management, LLC	sold off	-100	-	-	-%
Feb 15, 2024	Coastal Bridge Advisors, LLC	sold off	-100	-15,364	-	-%
Feb 14, 2024	STATE STREET CORP	sold off	-100	-25,495	-	-%
Feb 14, 2024	MARATHON ASSET MANAGEMENT LP	sold off	-100	-48,990	-	-%
Feb 14, 2024	Royal Bank of Canada	sold off	-100	-1,000	-	-%

Are Funds Buying or Selling UPH?

Are funds buying UPH calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own UPH

No. of Funds

Unveiling UpHealth, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Nov 29, 2023	pylypiv mariya	3.8%	677,580	SC 13D/A
Nov 28, 2023	machuca luis	1.2%	220,778	SC 13D
Nov 28, 2023	kathuria chirinjeev	21.7%	3,853,991	SC 13D/A
Nov 28, 2023	rey-giraud agnes	1.2%	220,778	SC 13D
Nov 28, 2023	beck martin s a	1.2%	220,778	SC 13D
Nov 28, 2023	locke nathan	1.2%	220,778	SC 13D
Nov 28, 2023	uphealth, inc.	3.8%	677,580	SC 13D
Nov 28, 2023	uphealth, inc.	21.7%	3,853,991	SC 13D
Nov 28, 2023	jennings jay walter	1.2%	220,778	SC 13D
Nov 28, 2023	guinan mark	1.2%	220,778	SC 13D

Recent SEC filings of UpHealth, Inc.

View All Filings

Date Filed	Form Type	Document
Apr 16, 2024	424B3	Prospectus Filed
Apr 15, 2024	8-K	Current Report
Apr 12, 2024	8-K	Current Report
Apr 05, 2024	10-K	Annual Report
Apr 02, 2024	NT 10-K	NT 10-K
Apr 01, 2024	8-K	Current Report
Mar 21, 2024	8-K	Current Report
Mar 20, 2024	424B3	Prospectus Filed
Mar 20, 2024	8-K	Current Report
Mar 19, 2024	424B3	Prospectus Filed

Peers (Alternatives to UpHealth, Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	449.3B	371.6B	-0.74%	-0.51%	20.08	1.21	14.64%	11.24%
CI	103.0B	195.3B	0.26%	37.72%	19.17	0.53	8.17%	-20.79%
CVS	85.3B	357.8B	-12.72%	-6.73%	10.21	0.24	10.95%	93.52%
HCA	84.4B	65.0B	-3.19%	11.59%	16.11	1.3	7.86%	-7.11%
CNC	40.8B	154.0B	-1.43%	12.08%	15.09	0.26	6.54%	124.79%
DVA	11.6B	12.1B	-0.12%	51.97%	16.83	0.96	4.57%	23.40%
UHS	11.5B	14.3B	-8.62%	17.22%	16.03	0.81	6.59%	6.24%
MID-CAP
CHE	9.3B	2.3B	-4.84%	8.83%	34.26	4.12	6.06%	9.17%
ACHC	6.6B	2.9B	-7.52%	-4.24%	-303.27	2.24	12.20%	-107.93%
AMN	2.2B	3.8B	-10.62%	-35.16%	10.28	0.57	-27.73%	-52.50%
AMEH	2.1B	1.4B	-5.65%	-0.29%	33.83	1.48	21.19%	34.42%
SMALL-CAP
ADUS	1.5B	1.1B	-8.44%	-16.43%	24.79	1.46	11.31%	35.83%
BKD	1.3B	3.0B	7.61%	59.68%	-6.76	0.42	6.74%	20.73%
BEAT	54.0M	-	-3.27%	-3.72%	-3.69	-	-	-12.94%
AMS	18.7M	21.3M	13.26%	5.28%	35.15	0.88	8.00%	-62.25%

UpHealth, Inc. News

Latest updates

UpHealth, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2
Revenue	-46.9%	17,349,000	32,681,000	37,823,000	42,145,000	40,497,000	38,666,000	43,668,000	35,972,000	33,905,000	45,192,000	31,882,000	12,816,000	4,379,077	44,890	56,038	915,995	720,744	933,853	218,104
Gross Profit	-47.1%	9,320,000	17,623,000	19,976,000	22,676,000	18,215,000	17,026,000	20,923,000	13,991,000	3,545,000	17,947,000	11,392,000	6,930,000	-	-	-	-	-	-	-
Operating Expenses	-83.9%	14,583,000	90,412,000	30,718,000	23,454,000	31,621,000	137,058,000	30,967,000	31,902,000	340,496,000	22,636,000	46,893,000	9,768,000	-	944,000	336,000	-	-	-	-
S&GA Expenses	-45.2%	1,503,000	2,745,000	2,421,000	4,619,000	4,329,000	4,648,000	3,539,000	3,434,000	4,968,000	3,090,000	1,695,000	885,000	-300,207	-	-	600,414	393,629	395,583	146,624
R&D Expenses	-87.1%	256,000	1,978,000	848,000	1,285,000	1,944,000	2,175,000	2,011,000	1,758,000	1,885,000	1,916,000	2,273,000	1,570,000	-	-	-	-	-	-	-
EBITDA Margin	7.9%	-0.18	-0.19	-1.17	-1.10	-1.19	-3.33	-1.82	-2.16	-2.51	-0.05	-0.89	-0.26	-0.25	-	-	-	-	-	-
Interest Expenses	11.7%	7,492,000	6,709,000	7,136,000	6,858,000	6,194,000	6,708,000	6,603,000	6,995,000	5,756,000	8,145,000	4,904,000	711,000	-	-	-	-	-	-	-
Income Taxes	-Infinity%	-2,085,000	-	867,000	-	8,360,000	-13,219,000	-2,232,000	-2,293,000	-2,064,000	6,700,000	-6,646,000	-400,000	342,216	-423,000	-	238,568	215,070	278,662	65,082
Earnings Before Taxes	39.9%	-12,109,000	-20,138,000	-17,752,000	-7,635,000	-18,821,000	-178,803,000	-14,697,000	-19,998,000	-338,148,500	37,683,000	-39,435,000	-2,872,000	-836,128	-944,000	-336,000	321,256	322,015	484,888	47,026
EBT Margin	-5.5%	-0.44	-0.42	-1.40	-1.33	-1.46	-3.62	-2.11	-2.45	-2.77	-0.06	-0.90	-0.29	-0.33	-0.37	-	-	-	-	-
Net Income	49.0%	-10,502,000	-20,605,000	-18,619,000	-7,635,000	-27,211,500	-165,762,000	-12,465,000	-17,705,000	-336,005,500	30,757,000	-32,789,000	-3,027,000	-1,126,000	-521,000	-336,000	-203,000	106,945	206,226	-18,056
Net Income Margin	8.8%	-0.44	-0.48	-1.38	-1.29	-1.41	-3.49	-2.11	-2.42	-2.76	-0.07	-0.76	-0.29	-0.41	-0.55	-	-	-	-	-
Free Cashflow	101.8%	123,000	-6,787,000	-9,591,000	-5,380,000	-6,488,000	-11,165,000	-6,890,000	-4,734,000	-16,252,000	-12,391,000	-33,387,000	-4,510,000	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																			(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2
Assets	-1.4%	232	235	295	339	340	345	79.00	549	569	887	898	150	262	175	176	176	176	176	175
Current Assets	-8.2%	20.00	22.00	71.00	44.00	43.00	52.00	77.00	98.00	107	126	150	0.00	13.00	1.00	1.00	1.00	2.00	2.00	3.00
Cash Equivalents	-23.8%	3.00	3.00	47.00	13.00	16.00	23.00	41.00	52.00	77.00	68.00	98.00	4.00	2.00	-	-	1.00	-	2.00	3.00
Inventory	-	-	-	0.00	0.00	0.00	3.00	0.00	3.00	3.00	3.00	3.00	-	0.00	-	-	-	-	-	-
Net PPE	-100.0%	-	10.00	14.00	14.00	14.00	20.00	27.00	47.00	56.00	58.00	55.00	-	0.00	-	-	-	-	-	-
Goodwill	0%	80.00	80.00	153	160	160	195	284	122	284	582	568	92.00	164	-	-	-	-	-	-
Liabilities	3.3%	177	171	210	235	234	214	219	233	235	260	304	173	42.00	28.00	14.00	1.00	1.00	1.00	0.00
Current Liabilities	-83.9%	27.00	166	60.00	69.00	69.00	67.00	90.00	102	97.00	116	156	4.00	35.00	0.00	1.00	1.00	0.00	1.00	0.00
Long Term Debt	-	-	-	141	149	146	143	1.00	102	98.00	99.00	96.00	-	0.00	-	-	-	-	-	-
LT Debt, Current	-100.0%	-	144	-	-	-	-	19.00	0.00	22.00	44.00	49.00	-	23.00	-	-	-	-	-	-
LT Debt, Non Current	-	147	-	141	149	146	143	1.00	102	98.00	99.00	96.00	-	0.00	-	-	-	-	-	-
Shareholder's Equity	-14.1%	55.00	64.00	85.00	104	105	131	301	316	334	627	594	321	221	5.00	5.00	5.00	5.00	5.00	5.00
Retained Earnings	-1.6%	-624	-614	-593	-574	-566	-538	-373	-360	-343	-7.16	-37.92	-4.77	-2.19	-0.64	-0.07	0.00	0.00	0.00	-0.02
Additional Paid-In Capital	0.1%	696	695	695	693	688	687	684	667	665	622	620	10.00	223	6.00	5.00	5.00	5.00	5.00	5.00
Accumulated Depreciation	-100.0%	-	13.00	13.00	11.00	10.00	9.00	8.00	-	5.00	-	1.00	-	0.00	-	-	-	-	-	-
Shares Outstanding	-100.0%	-	17.00	17.00	16.00	15.00	15.00	14.00	14.00	14.00	12.00	9.00	1.00	7.00	5.00	-	-	-	-	-
Minority Interest	-	-	-	1.00	1.00	1.00	1.00	14.00	15.00	15.00	1.00	15.00	-	-	-	-	-	-	-	-
Float	-	-	-	-	-	-	-	34.00	-	-	-	254	-	-	-	175	-	-	-	188

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																			(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2
Cashflow From Operations	112.3%	785	-6,398	-8,014	-4,039	-4,890	-9,710	-4,770	-3,071	-14,408	-11,181	-32,726	-4,502	-1,139	-	547	-547	-680	-516	-280
Share Based Compensation	83.1%	1,095	598	1,058	989	1,876	2,126	1,088	1,374	638	400	-	-	-	-	-	-	-	-	-
Cashflow From Investing	98.2%	-662	-36,021	53,284	-1,341	-1,598	-10,212	-2,120	-1,663	-1,894	-1,222	1,141	2,718	3,508	-	-164	165	307	72.00	-172,500
Cashflow From Financing	12.1%	-916	-1,042	-11,800	3,156	-562	1,392	-22,561	-1,019	23,349	-17,279	125,585	4,216	-	-	-	-	-85.00	-49.07	175,310
Buy Backs	-	-	-	-	-	-	-	-	-	-	-	17,000	-	-	-	-	-	-	-	-

UPH Income Statement

2023-12-31

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Total revenues	$ 129,998,000	$ 158,803,000
Total costs of revenues	60,403,000	88,648,000
Gross profit	69,595,000	70,155,000
Operating expenses:
Sales and marketing	11,288,000	15,951,000
Research and development	4,367,000	7,888,000
General and administrative	38,884,000	48,755,000
Depreciation and amortization	6,454,000	16,140,000
Stock-based compensation	3,740,000	6,464,000
Goodwill, intangible asset, and other long-lived asset impairments	49,958,000	116,239,000
Acquisition, integration, and transformation costs	44,476,000	20,111,000
Total operating expenses	159,167,000	231,548,000
Loss from operations	(89,572,000)	(161,393,000)
Other income (expense):
Interest expense	(28,195,000)	(26,500,000)
Deconsolidation, Gain (Loss), Amount	59,065,000	(37,708,000)
Loss on extinguishment of debt	0	(14,610,000)
Other income (expense), net, including interest income	1,068,000	7,892,000
Total other income (expense)	31,938,000	(70,926,000)
Net loss before income tax benefit	(57,634,000)	(232,319,000)
Income tax benefit	1,218,000	9,384,000
Net loss	(56,416,000)	(222,935,000)
Less: net income attributable to noncontrolling interests	1,423,000	65,000
Net loss attributable to UpHealth, Inc.	$ (57,839,000)	$ (223,000,000)
Net loss per share attributable to UpHealth, Inc.:
Basic (in dollars per share)	$ (3.26)	$ (15.17)
Diluted (in dollars per share)	$ (3.26)	$ (15.17)
Weighted average shares outstanding:
Basic (in shares)	17,724	14,699
Diluted (in shares)	17,724	14,699
Services
Total revenues	$ 110,039,000	$ 110,953,000
Total costs of revenues	51,073,000	62,954,000
Licenses and subscriptions
Total revenues	6,548,000	12,566,000
Total costs of revenues	1,147,000	1,260,000
Products
Total revenues	13,411,000	35,284,000
Total costs of revenues	$ 8,183,000	$ 24,434,000

UPH Balance Sheet

2023-12-31

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 2,548	$ 15,557
Accounts receivable, net	14,665	21,851
Inventories	0	161
Due from related parties	0	14
Prepaid expenses and other current assets	2,996	2,991
Assets held for sale, current	0	2,748
Total current assets	20,209	43,322
Property, plant and equipment, net	9,527	14,069
Operating lease right-of-use assets	1,902	7,213
Intangible assets, net	22,717	31,362
Goodwill	80,310	159,675
Equity investments	96,768	21,200
Other assets	375	438
Assets held for sale, noncurrent	0	62,525
Total assets	231,808	339,804
Current liabilities:
Accounts payable	11,723	17,983
Accrued expenses	10,590	38,763
Deferred revenue	48	2,738
Due to related party	948	229
Lease liabilities, current	3,522	5,475
Other liabilities, current	0	462
Liabilities held for sale, current	0	3,319
Total current liabilities	26,831	68,969
Related-party debt, noncurrent	0	281
Debt, noncurrent	146,524	145,962
Deferred tax liabilities	0	1,200
Lease liabilities, noncurrent	3,273	8,741
Other liabilities, noncurrent	76	727
Liabilities held for sale, noncurrent	0	7,787
Total liabilities	176,704	233,667
Commitments and Contingencies (Note 19)
Stockholders’ Equity
Preferred stock, $0.0001 par value, 1,000 shares authorized; none issued or outstanding at December 31, 2023 and 2022, respectively.	0	0
Common stock, $0.0001 par value, 300,000 shares authorized, 18,841 and 15,224 shares issued, 18,671 and 15,054 shares outstanding as of December 31, 2023 and 2022, respectively.	2	2
Additional paid in capital	696,150	688,355
Treasury stock, at cost	(17,000)	(17,000)
Accumulated deficit	(624,048)	(566,209)
Total UpHealth, Inc. stockholders’ equity	55,104	105,148
Noncontrolling interests	0	989
Total stockholders’ equity	55,104	106,137
Total liabilities and stockholders’ equity	$ 231,808	$ 339,804

About UpHealth, Inc.

UpHealth, Inc., together with its subsidiaries, operates as a digital health services company in the Americas, Europe, and Asia. The company operates through three segments Integrated Care Management, Virtual Care Infrastructure, and Services segments. The Integrated Care Management segment offers SyntraNet, an integrated health management platform that enables clinical and community-based care teams to share information, coordinate care, manage utilization, and improve health outcomes for individuals and populations. The Virtual Care Infrastructure segment provides the Martti platform, a digital health infrastructure that enables its partners to implement unique, private-label telehealth strategies customized to their specific needs and markets, including integrated telehealth and language access services. Its platform also offers telemedicine, such as telestroke, teleneurology, and telepsychiatry services. The Services segment offers behavioral health and pharmacy services, as well as operates HelloLyf CX platform for digital dispensary services and HelloLyf HX platform for digital hospital services; and provides diagnostic laboratory testing services. UpHealth, Inc. was founded in 2019 and is headquartered in Delray Beach, Florida.

CEO	Mr. Samuel J. Meckey
WEBSITE	https://uphealthinc.com
INDUSTRY	Healthcare Plans
EMPLOYEES	611

UpHealth, Inc. Frequently Asked Questions

What is the ticker symbol for UpHealth, Inc.? What does UPH stand for in stocks?

UPH is the stock ticker symbol of UpHealth, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of UpHealth, Inc. (UPH)?

As of Tue Apr 23 2024, market cap of UpHealth, Inc. is 1.75 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of UPH stock?

You can check UPH's fair value in chart for subscribers.

What is the fair value of UPH stock?

You can check UPH's fair value in chart for subscribers. The fair value of UpHealth, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of UpHealth, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for UPH so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is UpHealth, Inc. a good stock to buy?

The fair value guage provides a quick view whether UPH is over valued or under valued. Whether UpHealth, Inc. is cheap or expensive depends on the assumptions which impact UpHealth, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for UPH.

What is UpHealth, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 23 2024, UPH's PE ratio (Price to Earnings) is -30.5 and Price to Sales (PS) ratio is 13.46. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. UPH PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on UpHealth, Inc.'s stock?

In the past 10 years, UpHealth, Inc. has provided 0.151 (multiply by 100 for percentage) rate of return.